FDA Warning Letter — Innovative Intrathecal Solutions, Inc. dba Innovative Compounding Pharmacy

Case 555295 — FEI 3013556857

The FDA took a Warning Letter action against Innovative Intrathecal Solutions, Inc. dba Innovative Compounding Pharmacy on September 19, 2018 (Murrieta, CA). The action was issued by CDER and concerns drugs products. This facility has 2 recent FDA inspections on record.

Action Details

Facility
Innovative Intrathecal Solutions, Inc. dba Innovative Compounding Pharmacy
Date
September 19, 2018
Fiscal Year
2018
Product Type
Drugs
Center
CDER
Location
Murrieta, CA (United States)